AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03676855 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bladder dissection
Description: Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy
Study NCT03676855 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: bladder dissection
Description: Comparison between bladder dissection at the beginning of cesarean section For morbidly adherent placenta and between delaying dissection until planning for cesarean hysterectomy
Study NCT00554879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Needles placed bilaterally on the ears at the auriculotherapy points. Additional needles placed in both index fingers. A third set of needles inserted on both index fingers between LI-1 adn LI-2.
Study NCT00554879 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: Four needles will be placed on the left and right upper shoulder areas. Small circular adhesive tape will be placed in an ear area, but not on the acupuncture points.
Study NCT02073695 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Operative procedure to fix proximal humeral
Description: Operative fixation by the shoulder team at Torbay Hospital
Study NCT02073695 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Neutral Rotation Brace
Description: Performed at the end of the surgical procedure at Torbay Hospital
Study NCT02073695 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Physiotherapy review
Description: Physiotherapy review on day of surgery, and post-surgery at 6 weeks, 3 months and 1 year.
Study NCT02073695 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Functional outcome forms filled in
Study NCT02073695 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Postal functional outcome scores
Description: Sent to patient at 9 weeks post surgery
Study NCT02073695 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Post-operative Radiographs
Description: Performed at 6 weeks and 3 months at shoulder clinic appointment at Torbay Hospital
Study NCT00559650 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Will be standard therapy and placebo versus, Uptitration from 100-600µg/g, intravenous, over maximum 48 hours
Study NCT00559650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cinaciguat (BAY58-2667)
Description: Will be standard therapy and BAY 58-2667, Uptitration from 100-600µg/g, intravenous, over maximum 48 hours
Study NCT00310219 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: computed tomography
Study NCT00310219 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positron emission tomography
Study NCT03093831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: 560mg administered orally once daily.
Study NCT00414817 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Automated Phone-Based Refill Reminders
Description: The BREATHE EASY Medication Reminder Program uses interactive voice recognition phone technology to offer timely reminders to patients to refill their ICS medication, educational messages about ICS, and may offer to transfer them to a refill line or to speak with a pharmacist if they have questions.
Study NCT04886024 — intervention group
Intervention type: OTHER
Intervention: Advanced Glycation End Products (AGEs)
Description: Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.
Study NCT00738946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with AQ+ SP
Description: Amodiaquine (10 mg/kg over 3 days) and Sulfadoxine Pyrimethamine (25 mg of sulfadoxine + 1.25 mg of pyrimethamine per kg in a single dose) or placebo administered over 3 rounds of one month interval
Study NCT03515928 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic noise exposure
Description: Group will be exposed to 40kHz ultrasonic noise at 110-120 dB SPL for 15 minutes.
Study NCT03515928 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Pure Tone Audiometry
Description: Participants will undergo 2 (pre and post exposure) hearing tests
Study NCT03515928 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pure Tone Audiometry
Description: Participants will undergo 2 (pre and post exposure) hearing tests
Study NCT02269566 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HollisterStier
Description: 0.1 ml of 30 AU/ml for Df or Dp, 10 AU/ml for Cat hair, and/or 1:1/10 weight/volume for dog hair/dander 3 injections into an inguinal lymph node
Study NCT02269566 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 0.1 ml of normal saline 3 injections into an inguinal lymph node
Study NCT02668081 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic papillary balloon dilation
Description: treatment of endoscopic papillary balloon dilation
Study NCT02668081 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic sphincterotomy
Description: treatment of endoscopic sphincterotomy
Study NCT04272580 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: No preload was given before spinal anesthesia.
Study NCT04272580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 ml/kg group.
Description: 4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given before spinal anesthesia.
Study NCT04272580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8 ml/kg group.
Description: 8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given before spinal anesthesia.
Study NCT04272580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 12 ml/kg group.
Description: 12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given before spinal anesthesia.
Study NCT03824379 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Magnesium citrate
Description: magnesium citrate equivalent 20-30 mmol elemental magnesium
Study NCT03824379 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antidiabetic
Description: insulin or oral hypoglycemics
Study NCT00792792 — intervention group
Intervention type: DEVICE
Intervention: Modulated Imaging
Description: Modulated Imaging Spectroscopy
Study NCT04190940 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Assessment
Description: Patients will be asked to complete the behavioral assessment before and after their HIFU treatment or on and off their DBS treatment.
Study NCT03710863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM082
Description: Subjects will receive CM082 orally twice daily for two weeks followed by two weeks off in four-week cycles. The starting dose of 25mg BID will be increased by 100% to the maximum dose of 50mg BID.The treatment period is tentatively set at 1 year.
Study NCT05126394 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound guided serratus anterior plane block
Description: the patients receive local anesthetic (20 ml of Bupivacaine 0.25 %), injected superficial to the serratus muscle under ultrasound guidance.
Study NCT02235844 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical Cord Mesenchymal Stem Cells
Study NCT03997240 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chiropractic Applied Clinical Neuroscience
Description: Chiropractic Applied Clinical Neuroscience makes use of chiropractic care in addition to application of therapies designed to stimulate multisensory reintegration and cerebellar coordination. The multisensory reintegration and cerebellar therapies make use of the body's own sensory receptors as a target, with the purpose of realigning the brain's interpretation of different afferent signals. Observation of motor and autonomic output patterns during and after sensory stimulation afford the clinician real-time feedback, providing for adaptation of the sensory based protocol.
Study NCT04018144 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gingiva Biopsy Sampling
Description: Gingival samples of healthy individuals were collected by gingivectomy or crown lengthening procedure in the routine treatment protocol or before orthodontically indicated tooth extraction. Gingival samples of periodontitis patients were obtained during the scaling and root planning procedure. Posterior maxillary teeth (#4, #5, #6, and #7) were chosen for gingival sampling.
Study NCT01033344 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intradermal injection 1x8 administrations 2 weeks apart
Study NCT01033344 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cat-PAD
Description: Intradermal injection 1x8 administrations 2 weeks apart
Study NCT01033344 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cat-PAD
Description: Intradermal injection, 1x8 administrations 2 weeks apart, alternating active and placebo
Study NCT00947856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: brentuximab vedotin
Description: Every 3 weeks by IV infusion (1.2 or 1.8 mg/kg) until disease progression, unacceptable toxicity, or study closure
Study NCT03824379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antidiabetic
Description: insulin or oral hypoglycemics
Study NCT01514448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus (RAD001)
Description: Everolimus was used as commercially available formulated tablets of 10 mg strength
Study NCT03997240 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Chiropractic Applied Clinical Neuroscience
Description: Chiropractic Applied Clinical Neuroscience makes use of chiropractic care in addition to application of therapies designed to stimulate multisensory reintegration and cerebellar coordination. The multisensory reintegration and cerebellar therapies make use of the body's own sensory receptors as a target, with the purpose of realigning the brain's interpretation of different afferent signals. Observation of motor and autonomic output patterns during and after sensory stimulation afford the clinician real-time feedback, providing for adaptation of the sensory based protocol.
Study NCT04614181 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nestle Resource drink
Description: Beverage (Nestle RESOURCE). Each serving is 237ml containing 53.6g of carbohydrate and 9g of protein. Intervention group will consume two servings of the carbohydrate beverage (53.6g each, total of approximately 100g) on the day before surgery and one serving up to 6 hours prior to scheduled surgery time.
Study NCT04962555 — intervention group
Intervention type: PROCEDURE
Intervention: Meniscus Suture
Description: Patients with knee joint meniscus injury undergoing meniscus suture
Study NCT04962555 — intervention group
Intervention type: PROCEDURE
Intervention: Partial meniscus resection
Description: Patients with knee joint meniscus injury undergoing partial meniscus resection
Study NCT04962555 — intervention group
Intervention type: PROCEDURE
Intervention: Subtotal meniscus resection
Description: Patients with knee joint meniscus injury undergoing subtotal meniscus resection
Study NCT04962555 — intervention group
Intervention type: PROCEDURE
Intervention: Complete meniscectomy
Description: Patients with knee joint meniscus injury undergoing complete meniscectomy
Study NCT01497938 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature
Description: Automatic suspension of insulin delivery when glucose is low.
Study NCT01497938 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump
Description: No Automatic suspension of insulin delivery when glucose is low.
Study NCT03580343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tofacitinib
Description: tofacitinib extended release, 11mg, daily, oral
Study NCT01432132 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: Face-to-face audio recorded interview. It should take about 1 hour to complete.
Study NCT01432132 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaire about demographic information such as age and ethnicity.
Study NCT00671879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carisoprodol SR 700 mg
Description: 700 mg twice daily tablet
Study NCT00671879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carisoprodol SR 500 mg
Description: carisoprodol SR 500 mg tablet
Study NCT00671879 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo tablet
Study NCT01483872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NAC/Tigecycline/Heparin combination lock solution
Study NCT01483872 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard anticoagulant (Heparin or Citrate)
Study NCT01405976 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: life style modification, noninvasive ventilation, CPAP
Description: life style modification, noninvasive ventilation, CPAP
Study NCT03958279 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound measurement of residual volume in the urinary bladder
Description: Aim of this study is to asses post voiding residual volume by ultrasound scan 3th day after delivery with consecutive scan after 6 weeks, and determination of data dispersion among the population of primiparas.
Study NCT03958279 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaire
Description: Simple questionaire concerning voiding problems, infectious complications, medicaments and breastfeeding during puerperium period (6weeks)
Study NCT00614055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec/insulin aspart
Description: Formulation 1: Treat-to-target dose titration scheme, injection s.c., once daily
Study NCT00614055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec/insulin aspart
Description: Formulation 2: Treat-to-target dose titration scheme, injection s.c., once daily
Study NCT00614055 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin glargine
Description: Treat-to-target dose titration scheme, injection s.c., once daily
Study NCT00614055 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: Tablets, 1500-2000 mg/day
Study NCT04614181 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual fracture care as determined by clinical team
Study NCT02159157 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Exercise prescription
Description: A physical therapist will design an exercise plan for each participant on the intervention arm. The participants randomized to the intervention arm will also receive phone calls to assist with tracking the study participant's exercise and motivating the study participant to adhere to the exercise prescription.
Study NCT02131285 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory training
Study NCT05930626 — intervention group
Intervention type: OTHER
Intervention: Biomarkers of acrylamide, glycidol, POPs, PFAS
Description: These are food contaminants (acrylamide, glycidol) and environmental pollutants (POPs, PFAS). Assess the associations between biomarkers of acrylamide and glycidol exposure and disease outcomes in a case-cohort study based on two prospective cohorts with biobanks. The investigators also aim to assess the exposure-affected OMICS signatures and molecular pathways underlying disease development (specifically cardiovascular diseases such as myocardial infarction and stroke and cancer such as breast-, endometrial and colorectal cancer) for these exposures along with POPs and PFAS using a prospective cohort study utilizing and integrating various 'OMICs' technologies.
Study NCT00614055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metformin
Description: Tablets, 1500-2000 mg/day
Study NCT01991509 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LBR-101 IV
Description: LBR-101 Administered Intravenously
Study NCT03854084 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The cranial osteopathic techniques
Description: Technique of the temporal bones in favor of the free movement. Ear Pull technique: the hands of the osteopath holds the auricle of the individual with the thumb, index and the middle finger in a tweezer shape and with the elbows resting over the stretcher. Ruddy technique: The osteopath puts the thumbs on the eyelid of each eyeball.
Study NCT01991509 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: LBR-101 IV
Description: LBR-101 Administered Intravenously
Study NCT01991509 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LBR-101 SC
Description: LBR-101 Administered Subcutaneously
Study NCT03854084 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Simulation of the techniques was used in the interventional group
Study NCT03588156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benapenem
Description: Dose-escalation For 11 level dose groups A1 \~ A11(each 62.5mg/kg, 125mg/kg, 250mg/kg, 500mg/kg, 1000mg/kg 60min infusion, 1000mg/kg 30min infusion, 2000mg/kg 60 min infusion, 2000mg/kg 30min infusion, 3000mg/kg, 4000mg/kg), 10 subjects (8 for the study drug and 2 for placebo) are randomized to each dose group
Study NCT01991509 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: LBR-101 SC
Description: LBR-101 Administered Subcutaneously
Study NCT03588156 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT01506089 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 36 degrees Celsius
Description: Embryos in this group will be cultured in incubators set to 36 degrees Celsius.
Study NCT05488184 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Flavoured Oral Nutritional Supplement (ONS)
Description: Sensory analysis of different ONS of sweet (pineapple, tropical, brownie) and acid flavoured (tomato, ham)
Study NCT01199406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Description: 0.125% levobupivacaine 80 mL (100 mg) intraoperative, 20 mL subcutaneously and 60 mL intraperitoneally
Study NCT01199406 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Levobupivacaine
Description: 0.125% levobupivacaine 80 mL (100 mg) intraoperative, 20 mL subcutaneously and 60 mL intraperitoneally
Study NCT02708290 — intervention group
Intervention type: OTHER
Intervention: MITA Prefrontal Synthesis exercises - each activity adapts to deliver the exercise that is at the exact level of difficulty appropriate for a child at any given point in time
Description: Mental Imagery Therapy for Autism (MITA) is an early-intervention application for children with Autism Spectrum Disorder (ASD). MITA app uses adaptive-learning technologies, with fun, educational exercises that adapt to a child's abilities, resulting in a highly-customized learning experience. The MITA application is available for free in the Apple Store, Google Play, and Amazon App Store.~MITA verbal activities start with simple vocabulary-building exercises and progress toward exercises aimed at higher forms of language, such as noun-adjective combinations, spatial prepositions, recursion, and syntax. All exercises are deliberately limited to as few nouns as possible since the aim is not to expand a child's one-word vocabulary, but rather to teach him/her to integrate mental objects in novel ways by utilizing prefrontal synthesis (PFS). MITA activities outside of the verbal domain aim to provide the same PFS training visually through implicit instructions.
Study NCT04511520 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical training program
Study NCT04511520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Study NCT04637711 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Focus clearing + whole breast exploration and washing + one-stage micro plastic surgery No Intervention: Extensive lesion excision
Description: Only visible lesions and necrotic tissues, such as abscess cavity, sinus tract and fistula, were removed intraoperatively, while normal glands and fat were retained. Preoperative ultrasound was used to locate the lesion area and then the surgical incision was designed. Intraoperative ultrasound examination of latent small lesions, resection of lesions visible under ultrasound, and then a full breast exploration, one finger page incision interval.Radially cut from the base to the subcutaneous, lesions were found and treated locally. After removal of lesion, fully using the syringe, in turn, use of 3% hydrogen peroxide solution, 1% eniodine, saline water is widely jet pulse washing, and around the lesions base. After rinsing, soak in 1% active iodine for 10min, then rinse with normal saline until the liquid is clear. Breast tumor Surgery (Oncoplastic Breast Surgery, OBS) core technology (volume replacement and volume replacement).
Study NCT00405431 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Restasis
Description: 1 drop in study eye twice a day X 6 months
Study NCT00405431 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Endura (artificial tears)
Description: 1 drop in study eye twice a day X 6 months